GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sorrento Therapeutics SRNE · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Sorrento Therapeutics

Our reporting

We have not reported on Sorrento Therapeutics yet.

Next results

6 Nov 2026

Due on 6 Nov 2026. Analysts expect earnings of 0.42 a share on revenue of $18.2m.

Past results

Reported against what analysts expected

11 Aug 202315 May 202315 Mar 20238 Nov 202215 Aug 20225 May 2022
Earnings per share-0.17-0.26-0.34-0.20-0.54-0.12
Forecast-0.15-0.16-0.19-0.25-0.23-0.25
Revenue$15.0m$16.3m$62.8m$17.4m$11.5m$18.4m
Forecast$22.6m$20.0m$18.2m$13.6m$18.8m$19.8m

Key events

  1. 1 Aug 201325-to-1 reverse split
  2. 7 Oct 200810-to-1 reverse split
  3. 16 Mar 200720-to-1 reverse split
  4. 19 Jan 2007Listed

Sorrento Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.